Skip to main content

Table 1 Clinicopathological findings from 20 patients with extra nodal nasal-type T/NK lymphoma.

From: Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas

Case

Age

Sex

Tumour localized

Histology

CD56

Clinical stage

Treatment

Follow-up

1

57

M

Palate

Mixture

+

III-B

Ct+Rt

DWD (10 m)

2

30

F

Nasal cavity

Mixture

+

I-B

Ct+Rt

DWD (16 m)

3

42

F

Nasal cavity

Mixture

+

IV-B

Ct

DWD (3 m)

4

32

M

Palate

Mixture

+

II-A

Ct+Rt

DWD (8 m)

5

93

F

Nasal cavity

Large cells

+

II-B

Rt

DWD (1 m)

6

49

M

Nasal cavity

Mixture

+

II-B

Ct+Rt

AWOD (16 m)

7

38

M

Nasopharynx

Mixture

+

I-A

Ct+Rt

AWOD (10 m)

8

23

F

Palate

Mixture

+

II-B

Ct+Rt

AWOD (12 m)

9

23

M

Nasopharynx

Mixture

+

III-A

Ct+Rt

AWOD (60 m)

10

28

F

Nasal cavity

Mixture

+

III-B

Ct+Rt

DWD (4 m)

11

67

F

Nasopharynx

Mixture

+

III-B

Ct+Rt

DWD (36 m)

12

43

M

Nasal cavity

Mixture

+

IV-B

Ct

DWD (1 m)

13

62

M

Nasal cavity

Mixture

+

II-B

Rt

DWD (1 m)

14

66

M

Nasal cavity

Large cells

+

II-A

Ct+Rt

AWOD (60 m)

15

36

M

Nasal cavity

Mixture

+

IV-B

Ct

DWD (1 m)

16

54

M

Nasal cavity

Mixture

+

IV-B

Ct+Rt

DWD (3 m)

17

57

F

Nasal cavity

Large cells

+

IV-B

Rt

DWD (1 m)

18

63

M

Nasal cavity

Mixture

+

I-A

Ct+Rt

AWD (132 m)

19

22

M

Nasal cavity

Mixture

+

IV-B

None

DWD (1 m)

20

43

M

Palate

Mixture

+

IV-B

Ct

DWD (3 m)

  1. Ct, chemotherapy; Rt, radiotherapy; DWD, death with disease; AWOD, alive without disease; AWD, alive with disease.